Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Observational

Virtual Reality Application for Assessing Neck Movement and Position Sense

NCT07190014 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2025-10-25
Last updated
2025-09-29

Condition(s) studied

Chronic Neck Pain

Study summary

The goal of this observational study is to examine whether a virtual reality application developed by our team can be used to evaluate cervical range of motion (ROM) and joint position sense (JPS) in individuals with chronic neck pain.

The main questions it aims to answer are:

* Does the virtual reality application provide reliable measurements of cervical ROM?
* Does the application accurately assess cervical JPS when compared with a standard clinical tool (Cervical Range of Motion device, CROM)?

Researchers will compare results from the VR application with results from the CROM device to see if the two methods give similar outcomes.

Participants will:

* Complete a demographic and clinical evaluation.
* Perform standardized neck movements (flexion, extension, left/right lateral flexion, left/right rotation).
* Be assessed using both the CROM device and the VR application for ROM and JPS.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Chronic Neck Pain (CNP) participants * Age 18-65.  * ≥ 6 months of neck pain.  * Willing to participate (informed consent).  Healthy volunteers * Age 18-65.  * No neck pain complaints.  * Willing to participate (informed consent).  Exclusion Criteria: * Prior adverse virtual reality experience.  * Photophobia: UPSIS-12 score \> 12.  * Migraine screen: ≥2 "yes" on ID-Migraine.  * Any neurological deficit.  * History of spinal surgery.  * Medical conditions that could interfere with participation: orthopedic, inflammatory, cardiovascular, rheumatologic, or vestibular problems.  * Pregnancy.

Primary outcome measure(s)

  • Cervical Range of Motion (ROM) Measurements — At baseline, during a single assessment session (Day 1).
    Cervical ROM will be assessed in six directions (flexion, extension, right/left lateral flexion, right/left rotation). Measurements will be obtained using both the CROM device and the virtual reality assessment module developed by the research team. Results will be compared to evaluate the validity of the VR-based system.
  • Cervical Joint Position Sense (JPS) Error — At baseline, during a single assessment session (Day 1).
    JPS will be evaluated by asking participants to move their head to 65% of the available ROM in a given direction, return to the neutral position, and then attempt to relocate the same target position. Errors will be recorded in degrees. Measurements will be taken with both the CROM device and the VR assessment module, and results will be compared.

Trial sites (1)

FacilityCityRegionStatus
Hacettepe University Hospital Department of Neurosurgery Ankara Ankara
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07190014 on ClinicalTrials.gov ↗ ← All trials in Turkey